The expression of COL11A1 in colon adenocarcinoma was analyzed based on the different clinicopathological parameters like sample type, individual cancer stage, patient’s sex and age, histological subtype, nodal metastasis status, and TP53 mutation status using the UALCAN server (Figure 2 and Supplementary Table 2). The gene discussed is TP53; the disease is colon adenocarcinoma.